Overview

Stromal Vascular Fraction From Lipoaspirate to Treatment of Chronic Non-healing Wound

Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This is a Phase I, open-label, single arm study to demonstrate the safety of Antria Cell Preparation Process during fat grafting augmented with autologous adipose derived stromal vascular fraction to demonstrate the safety and efficacy of administration of SVF enriched fat grafting in chronic wounds
Phase:
Phase 1
Details
Lead Sponsor:
Antria